Company Search:
Advanced Search
Sponsored Links
Synthetic Biologics Inc Company Snapshot
Synthetic Biologics Inc operates within the Pharmaceutical preparations sector. In addition to historical fundamental analyses, the complete report available to purchase compares Synthetic Biologics Inc with three other companies in this sector in the United States: Elite Pharmaceuticals, Inc. (2010 sales of $3.34 million of which 77% was Manufacturing Fees), Acura Pharmaceuticals, Inc. ($3.31 million of which 100% was Generic Drug Products), and Biodelivery Sciences International, Inc. ($3.40 million of which 100% was Sponsored Research).

Sales Analysis.
  Stock Performance Chart for Synthetic Biologics Inc
  Stock Data: Recent Stock Performance:
  Current Price (12/6/2019): .41
(Figures in U.S. Dollars)
1 Week 2.1%   13 Weeks -7.0%  
4 Weeks -10.9%   52 Weeks -39.4%  
Synthetic Biologics Inc Key Data:
  Ticker: SYN Country: United States
  Exchanges: ASE Major Industry: Pharmaceuticals & Biotechnology
    Sub Industry: Pharmaceutical Preparations
  2010 Sales 3,164,512
(Year Ending Jan 2011).
Employees: 13
  Currency: U.S. Dollars Market Cap: 6,890,636
  Fiscal Yr Ends: December Shares Outstanding: 16,806,430
  Share Type: Common Closely Held Shares: 15,406
Feedback | Terms and Conditions | Privacy Policy | Site Index
CorporateInformation® website and selected data Copyright © 2000 - by The Winthrop Corporation. All Rights Reserved. Except for quotations by established news media, no pages on this site may be reproduced, stored in a retrieval system, or transmitted for commercial purposes, in any form or by any means, electronic, mechanical, photocopying, recording, or otherwise without prior written permission. Information is believed reliable, but accuracy, completeness and opinions are not guaranteed.